Burning Rock Biotech Ltd Earnings
The next earnings date for Burning Rock Biotech Ltd has not yet been scheduled.
Analyst Estimates of Burning Rock Biotech Ltd Earnings
| No results. | |
What is an Earnings Date
An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.
Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.
Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.
Burning Rock Biotech Ltd Earnings: Historical
| 09/10/2026 | --- | $-0.20 | --- |
| 06/02/2026 | --- | $-0.24 | --- |
| 11/20/2025 | --- | $-1.56 | --- |
| 09/08/2025 | --- | $-0.90 | --- |
| 06/06/2025 | --- | $-1.25 | --- |
| 03/25/2025 | --- | $-7.87 | -671.57% |
| 12/18/2024 | After Market | $-0.48 | --- |
| 08/29/2024 | Before Market | $-1.45 | -34.63% |
| 05/29/2024 | Before Market | $-1.65 | -49.91% |
| 03/28/2024 | After Market | $-3.07 | 5.25% |
More About Burning Rock Biotech Ltd
Burning Rock Biotech Limited develops and sells cancer therapy selection tests in the People's Republic of China and the United States. It operates in three segments: Central Laboratory Business, In-Hospital Business, and Pharma Research and Development Services. The company offers next-generation sequencing (NGS)-based tissue, liquid biopsy cancer therapy selection, and prognosis prediction tests for various cancer types, including lung cancer, gastrointestinal cancer, prostate cancer, breast cancer, lymphomas, thyroid cancer, colorectal cancer, ovarian cancer, pancreatic cancer, and bladder cancer using tissue and liquid biopsy samples. Its key products include OncoScreen Focus, a multi-gene tumor mutation co-detection test kit for non-small cell lung cancer (NSCLC) patients; OncoScreen Plus, a pan-cancer test for tissue samples; OncoCompass Plus, a corresponding test for liquid biopsy samples; OncoCompass Target, a ctDNA liquid biopsy-based test for NSCLC; and ColonCore for assessing microsatellite loci related to MSI status and detecting mutations in genes associated with gastrointestinal and related cancers. The company also provides CanCatch, a pre-operative ctDNA detection and post-operative minimal residual disease calling for relapsed patients; OncoMaster, an automatic NGS data analysis and report interpretation machine; as well as Magnis BR-customized version of its key products. In addition, it engages in the facilitation of laboratory equipment sales and sales of reagent kits. The company has a development and commercialization agreement with Myriad Genetics, Inc. to in-license Myriad myChoice tumor testing in China; and collaborations on clinical trials and research studies with AstraZeneca, Bayer, Johnson & Johnson, CStone, BeiGene, Abbisko Therapeutics, IMPACT Therapeutics, Boehringer Ingelheim, and Merck KGaA. Burning Rock Biotech Limited was founded in 2014 and is headquartered in Guangzhou, the People's Republic of China.
“Burning Rock Biotech Ltd Earnings” Can Refer to the Burning Rock Biotech Ltd Earnings Date
Some people say “Burning Rock Biotech Ltd earnings” as a shortform way to refer to the earnings date.
For example, someone might say, “I plan to hold my Burning Rock Biotech Ltd position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.
Owning Burning Rock Biotech Ltd Stock on the Earnings Date
If you own Burning Rock Biotech Ltd stock (BNR) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.
A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Burning Rock Biotech Ltd might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.
There is often a big audience of investors involved with trading Burning Rock Biotech Ltd shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.
These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.
Learning More Burning Rock Biotech Ltd Earnings
You can contact us any time if you would like to ask questions about Burning Rock Biotech Ltd earnings or anything else related to the stock market.